PMI Investor Deadline Approaching: Faruqi & Faruqi LLP Reminds Picard Medical Investors of April 13, 2026 Class Action Deadline

The deadline for investors in Picard Medical, Inc. (PMI) to seek appointment as lead plaintiff in a pending securities class action lawsuit is quickly approaching. National securities litigation firm Faruqi & Faruqi LLP is reminding affected shareholders that they must act before April 13, 2026 if they wish to participate in or potentially lead the legal proceedings.

The lawsuit alleges that Picard Medical and certain of its executives violated federal securities laws by making false and misleading statements that allegedly impacted investors and caused significant financial losses. Shareholders who purchased or acquired PMI securities during the specified class period may be eligible to seek compensation.

Overview of the Securities Class Action

The class action lawsuit was filed on behalf of investors who acquired Picard Medical securities during the designated class period. According to the complaint, the company and certain senior officers allegedly misrepresented key facts about its business operations, financial outlook, and regulatory compliance.

Specifically, the lawsuit claims that:

• The company issued statements that were materially false and misleading.
• Certain operational and financial challenges were not fully disclosed to investors.
• The alleged misrepresentations artificially inflated the price of PMI’s stock.
• When the truth was revealed, the stock price declined sharply, resulting in investor losses.

The securities litigation seeks to recover damages for investors who were negatively impacted by the alleged misconduct.

Who May Be Affected

Investors who purchased or otherwise acquired PMI securities during the class period may have legal rights. The class period, as defined in the complaint, covers the timeframe in which the alleged misleading statements were made and when the stock was purportedly trading at inflated prices.

Shareholders who suffered losses during this period are encouraged to review their transactions and consider consulting legal counsel to understand their options.

April 13, 2026: Critical Deadline to Seek Lead Plaintiff Status

The court has set April 13, 2026 as the deadline for investors to file a motion to be appointed lead plaintiff in the case. The lead plaintiff plays a central role in securities class action litigation, representing the interests of all class members.

Being appointed as lead plaintiff does not require investors to bear the costs of litigation. In most securities class actions, attorneys’ fees are paid only if the case results in a recovery for the class.

Importantly, investors do not need to seek lead plaintiff status to remain part of the class and potentially share in any recovery. However, those with significant losses may wish to consider the opportunity.

Allegations Against Picard Medical

The complaint alleges that Picard Medical failed to provide accurate disclosures regarding certain business risks and financial conditions. These alleged omissions and misstatements are said to have misled the investing public.

When corrective information allegedly became public, the company’s stock price experienced volatility and decline, leading to investor losses. The lawsuit contends that this price drop was directly linked to the disclosure of previously undisclosed information.

It is important to note that the allegations have not yet been proven in court. Picard Medical and the individual defendants are presumed innocent unless and until liability is established through litigation or settlement.

About Faruqi & Faruqi LLP

Faruqi & Faruqi LLP is a nationally recognized law firm with extensive experience in complex civil litigation, particularly securities class actions. The firm has recovered hundreds of millions of dollars on behalf of investors in cases involving corporate fraud, accounting irregularities, and misleading financial disclosures.

The firm routinely represents institutional and individual investors across the United States and abroad. Its attorneys focus on protecting shareholder rights and holding corporations accountable for alleged violations of securities laws.

What Investors Should Do Now

Investors who believe they may be affected should:

1. Review their PMI stock purchase and sale records.
2. Calculate any potential losses incurred during the class period.
3. Consult with qualified securities litigation counsel to discuss their rights.
4. Determine whether they wish to seek appointment as lead plaintiff before the April 13, 2026 deadline.

Taking timely action is critical, as courts strictly enforce filing deadlines in securities class action cases.

Understanding Securities Class Actions

Securities class action lawsuits are legal proceedings brought on behalf of a group of investors who claim they were harmed by violations of federal securities laws. These cases often involve allegations of:

• False or misleading financial statements
• Failure to disclose material risks
• Accounting fraud
• Insider trading or other misconduct

The purpose of such lawsuits is to compensate investors for losses allegedly caused by corporate misconduct and to promote transparency in financial markets.

No Cost to Participate

Typically, securities class actions are handled on a contingency fee basis. This means that investors do not pay attorneys’ fees unless there is a recovery. Legal costs are generally advanced by the law firm and reimbursed only if the case is successful.

This structure allows investors to pursue justice without upfront financial burden.

Importance of Timely Action

Deadlines in securities litigation are strictly enforced. Investors who miss the April 13, 2026 deadline to seek lead plaintiff status will generally lose the opportunity to take on that role in the case. However, they may still remain members of the class unless they choose to opt out.

Proactive steps today can help protect shareholder rights and ensure proper representation in the legal process.

Potential Outcomes of the Litigation

The case may proceed through several stages, including:

• Motions to dismiss
• Discovery and evidence gathering
• Settlement negotiations
• Trial, if necessary

Many securities class actions resolve through negotiated settlements, though outcomes vary based on the facts and legal issues involved.

Investor Rights and Legal Protections

Federal securities laws are designed to protect investors by requiring companies to provide truthful, accurate, and complete information. When companies allegedly fail to meet these obligations, shareholders have the right to seek redress through the courts.

The PMI class action underscores the importance of corporate transparency and accountability in public markets.

Conclusion

With the April 13, 2026 deadline rapidly approaching, Picard Medical investors are urged to carefully evaluate their legal options. Faruqi & Faruqi LLP continues to investigate the allegations and encourages affected shareholders to act promptly if they wish to pursue lead plaintiff status.

Investors who purchased PMI securities during the class period and experienced financial losses should consider seeking legal advice to determine the best course of action. Staying informed and meeting critical deadlines can make a significant difference in protecting investor rights.

#PMIInvestors #SecuritiesClassAction #InvestorDeadline #FaruqiAndFaruqi #SlimScan #GrowthStocks #CANSLIM